Understanding Pharma

Understanding Pharma
Author :
Publisher : Pharmaceutical Press
Total Pages : 311
Release :
ISBN-10 : 0976309637
ISBN-13 : 9780976309635
Rating : 4/5 (635 Downloads)

Book Synopsis Understanding Pharma by : John J. Campbell

Download or read book Understanding Pharma written by John J. Campbell and published by Pharmaceutical Press. This book was released on 2008-01-01 with total page 311 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Understanding Pharma Related Books

Understanding Pharma
Language: en
Pages: 311
Authors: John J. Campbell
Categories: Pharmaceutical industry
Type: BOOK - Published: 2008-01-01 - Publisher: Pharmaceutical Press

DOWNLOAD EBOOK

The Global Pharmaceutical Industry
Language: en
Pages: 95
Authors: Daniel Hoffman
Categories: Business & Economics
Type: BOOK - Published: 2020-07-06 - Publisher: Routledge

DOWNLOAD EBOOK

The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)
Language: en
Pages: 451
Authors: John Braithwaite
Categories: Social Science
Type: BOOK - Published: 2013-10-08 - Publisher: Routledge

DOWNLOAD EBOOK

First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior ex
Regulatory Affairs in the Pharmaceutical Industry
Language: en
Pages: 287
Authors: Javed Ali
Categories: Medical
Type: BOOK - Published: 2021-11-14 - Publisher: Academic Press

DOWNLOAD EBOOK

Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures c
Leading Pharmaceutical Innovation
Language: en
Pages: 184
Authors: Oliver Gassmann
Categories: Business & Economics
Type: BOOK - Published: 2013-06-05 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book